Evidence map›Paper›PMID 35864516›Full record

ArticleJournal of medical case reports2022

An incidental finding of retroperitoneal paraganglioma during the coronavirus disease 2019 pandemic: a case report.

K Ben Hamida, M Slimane, A Mlouka, N Boujelbene, S Essghaier, K Rahal

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

K Ben HamidaDepartment of Surgical Oncology, Salah Azaiez Institute, Boulevard du 9 Avril 1938, 1006, Tunis, Tunisia. karim.ben.hamida.92@gmail.com.
M SlimaneDepartment of Surgical Oncology, Salah Azaiez Institute, Boulevard du 9 Avril 1938, 1006, Tunis, Tunisia.
A MloukaDepartment of Radiology, Salah Azaiez Institute, Boulevard du 9 Avril 1938, 1006, Tunis, Tunisia.
N BoujelbeneDepartment of Pathology, Salah Azaiez Institute, Boulevard du 9 Avril 1938, 1006, Tunis, Tunisia.
S EssghaierDepartment of Radiology, Salah Azaiez Institute, Boulevard du 9 Avril 1938, 1006, Tunis, Tunisia.
K RahalDepartment of Surgical Oncology, Salah Azaiez Institute, Boulevard du 9 Avril 1938, 1006, Tunis, Tunisia.
Institut Salah-Azaïz · TNTunis El Manar University · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExtra-adrenal paraganglioma of the retroperitoneum is a very rare neoplasm arising from cells of the primitive neural crest. Although paragangliomas are considered benign and are often found incidentally, they have the potential to metastasize. CASE PRESENTATION: We report the case of a 68-year-old Caucasian woman with an incidental diagnosis of retroperitoneal paraganglioma that was discovered on chest computed tomography performed for high suspicion of coronavirus disease 2019 pneumonia. The patient showed no metastasis and was successfully treated by complete surgical removal of the tumor.

conclusionAs the diagnosis of paragangliomas is often delayed because of absent clinical symptoms, they represent a significant diagnostic challenge. Although surgery may exacerbate coronavirus disease 2019 infection, surgical resection of this tumor is prioritized, given its malignancy potential, and it must be performed as soon as no infection is detected.

Indexed as

COVID-19ParagangliomaRetroperitoneal NeoplasmsAgedFemaleHumansIncidental FindingsPandemicsCOVID-19Incidental findingParagangliomaRetroperitoneum

Identifiers

PMID35864516
PMCPMC9302867
OpenAlexW4286207933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.